Preparation and in vitro and in vivo characterization of composite microcapsules for cell encapsulation

International Journal of Pharmaceutics

Volumn 324, Issue 1, 2006, Pages 27-36

  Blasi, Paolo ^a   Giovagnoli, Stefano ^a   Schoubben, Aurélie ^a   Ricci, Maurizio ^a   Rossi, Carlo ^a   Luca, Giovanni ^b   Basta, Giuseppe ^b   Calafiore, Riccardo ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Alginate; Cell encapsulation; Inflammation; Ketoprofen; NSAIDs; PLA; PLGA

Indexed keywords

ALGINIC ACID; HYDROXYPROPYLMETHYLCELLULOSE; KETOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PLASTICIZER; POLYGLACTIN; POLYMER; POLYORNITHINE; RESOMER;

ANIMAL EXPERIMENT; ARTICLE; BIODEGRADABLE IMPLANT; CELL ENCAPSULATION; CELL FUNCTION; CELL TRANSPLANTATION; COMPOSITE MATERIAL; CONTROLLED STUDY; DISPERSION; DRUG RELEASE; DRUG STRUCTURE; IN VITRO STUDY; IN VIVO STUDY; LIFESPAN; MALE; MEDICAL ASSESSMENT; MICROCAPSULE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; OBSERVATION; PARAMETERS OF MEASUREMENT AND ANALYSIS; PARTICLE SIZE; PRIORITY JOURNAL;

BIOCOMPATIBLE MATERIALS; CAPSULES; DIFFERENTIAL THERMAL ANALYSIS; DRUG COMPOUNDING; LACTIC ACID; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; POLYGLYCOLIC ACID; POLYMERS; SOLVENTS;

EID: 33749646988     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.07.049     Document Type: Article

References (38)

1. Agrawal C.M., and Athanasiou K.A. Technique to control pH in vicinity of biodegrading PLA-PGA implants. J. Biomed. Mater. Res. 38 (1997) 105-114
2. Anderson J.M., and Langone J.J. Issues and perspectives on the biocompatibility and immunotoxicity evaluation of implanted controlled release systems. J. Control. Rel 57 (1999) 107-113
3. Babensee J.E., Anderson J.M., McIntire L.V., and Mikos A.G. Host response to tissue engineered devices. Adv. Drug Deliver. Rev. 33 (1998) 111-139
4. Basta G., Sarchielli P., Luca G., Racanicchi L., Nastruzzi C., Guido L., Mancuso F., Macchiarulo G., Calabrese G., Brunetti P., and Calafiore R. Optimized parameters for microencapsulation of islet cells: an in vitro study clueing on islet graft immunoprotecion in type 1 diabetes mellitus. Transpl. Immunol. 13 (2004) 289-296
5. Bizzarri C., Pagliei S., Brandolini L., Mascagni P., Caselli G., Transidico P., Sozzani S., and Bertini R. Selective inhibition of interleukin-8-induced neutrophil chemotaxis by ketoprofen isomers. Biochem. Pharmacol. 61 (2001) 1429-1437
6. Blasi P., D'Souza S.S., Selmin F., and Deluca P.P. Plasticizing effect of water on poly(lactide-co-glycolide). J. Control. Rel. 108 (2005) 1-9
7. Bünger C.M., Tiefenbach B., Jahnke A., Gerlach C., Freier Th., Schmitz K.P., Hopt U.T., Schareck W., Klar E., and de Vos P. Deletion of the tissue response against alginate-pll capsules by temporary release of co-encapsulated steroids. Biomaterials 26 (2005) 2353-2360
8. Calafiore R., and Basta G. Alginate/poly-l-ornithine microcapsules for pancreatic islet cell immunoprotection. In: Kühtreiber W.M., Lanza R.P., and Chick W.L. (Eds). Cell Encapsulation, Technology and Therapeutics (1999), Birkhäuser, New York 138-150
9. Calafiore R. Bioartificial pancreas. In: Dumitriu S. (Ed). Polymeric Biomaterials (2002), Marcel Dekker, New York 983-1005
10. Calafiore R. Alginate microcapsules for pancreatic islet cell graft immunoprotection: struggle and progress towards the final cure for type 1 diabetes mellitus. Expert. Opin. Biol. Ther. 3 (2003) 201-205
11. Calafiore R., Basta G., Luca G., Lemmi A., Montanucci M.P., Calabrese G., Racanicchi L., Mancuso F., and Brunetti P. Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes. Diab. Care 29 (2006) 137-138
12. de Groot M., Schuurs T.A., and van Schilfgaarde R. Causes of limited survival of microencapsulated pancreatic islet grafts. J. Surg. Res. 121 (2004) 141-150
13. den Dunnen W.F.A., Robinson P.H., van Wesse R., Pennings A.J., van Leeuwen M.B.M., and Schakenraad J.M. Long-term evaluation of degradation and foreign-body reaction of subcutaneously implanted poly(d,l-lactide-ε-caprolactone). J. Biomed. Mater. Res. 36 (1997) 337-346
14. de Vos P., Hamel A.F., and Tatarkiewicz K. Considerations for successful transplantation of encapsulated pancreatic islets. Diabetologia 45 (2002) 159-173
15. de Vos P., van Hoogmoed C.G., de Haan B.J., and Busscher H.J. Tissue responses against immunoisolating alginate-PLL capsules in the immediate post-transplant period. J. Biomed. Mater. Res. 62 (2002) 430-437
16. de Vos P., van Hoogmoed G.C., van Zanten J., Netter S., Strubbe J.H., and Busscher H.J. Long-term biocompatibility, chemistry, and function of microencapsulated pancreatic islets. Biomaterials 24 (2003) 305-312
17. Gabor F., Ertl B., Wirth M., and Mallinger R. Ketoprofen-poly(d,l-lactic-co-glicolic acid) microspheres: influence of manufacturing parameters and type of polymer on the release characteristics. J. Microencapsul. 16 (1999) 1-12
18. Giovagnoli, S., Blasi, P., Ricci, M., Rossi, C., 2004. Biodegradabile microspheres as carrier for native superoxide dismutase and catalase delivery. AAPS Pharm. Sci. Technol. 5, 4 (article 51, http://www.aapspharmscitech.org).
19. Giovagnoli S., Luca G., Casaburi I., Blasi P., Macchiarulo G., Ricci M., Calvitti M., Basta G., Calafiore R., and Rossi C. Long-term delivery of superoxide dismutase and catalase entrapped in poly(lactide-co-glycolide) microspheres: in vitro effects on isolated neonatal porcine pancreatic cell clusters. J. Control. Rel. 107 (2005) 395-407
20. Johansson U., Olsson A., Gabrielsson S., Nilsson B., and Korsgren O. Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation. Biochem. Biophys. Res. Commun. 308 (2003) 474-479
21. Karlsson O.J., Stubbs J.M., Karlsson L.E., and Sundberg D.C. Estimating diffusion coefficients for small molecules in polymers and polymer solutions. Polymer 42 (2001) 4915-4923
22. Luca, G., Calafiore, R., Basta, G., Ricci, M., Calvitti, M., Neri, L., Nastruzzi, C., Becchetti, E., Capitani, S., Brunetti, P., Rossi, C., 2001. Improved function of rat islets upon co-microencapsulation with Sertoli's cells in alginate/poly-l-ornithine. AAPS Pharm. Sci. Technol., 2, 3 (article 15, http://www.aapspharmscitech.org).
23. Luca G., Calvitti M., Basta G., Baroni T., Neri L.M., Becchetti E., Capitani S., Novaes G., Correa-Giannella M.L., Kalapothakis E., Engler S.S., Eliaschewitz F.G., Sogayar M.C., Fanelli C., Brunetti P., and Calafiore R. Mitogenic effects of Brazilian arthropod venom on isolated islet beta cells: in vitro morphologic ultrastructural and functional studies. J. Invest. Med. 51 (2003) 79-85
24. Luca G., Basta G., Calafiore R., Rossi C., Giovagnoli S., Esposito E., and Nastruzzi C. Multifunctional microcapsules for pancreatic islet cell entrapment: design, preparation and in vitro characterization. Biomaterials 24 (2003) 3101-3114
25. Lund T., and Østerud B. The effect of TNF-α, PMA, and LPS on plasma and cell-associated IL-8 in human leukocytes. Thromb. Res. 113 (2004) 75-83
26. Mitchell J.A., and Warner T.D. Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy. Br. J. Pharmacol. 128 (1999) 1121-1132
27. Mukaida N., Harada A., and Matsushima K. Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (mcaf/mcp-1), chemokines essentially involved in inflammatory and immune reactions. Cytokine Growth F. R. 9 (1998) 9-23
28. Omer A., Keegan M., Czismadia E., De Vos P., Van Rooijen N., Bonner-Weir S., and Weir G.C. Macrophage depletion improves survival of porcine neonatal pancreatic cell clusters contained in alginate macrocapsules transplanted into rats. Xenotransplantation 10 (2003) 240-251
29. Orive G., Hernandez R.M., Gascon A.R., Calafiore R., Chang T.M.S., de Vos P., Hortelano G., Hunkeler D., Lacìk I., Shapiro J.A.M., and Pedraz J.L. Cell encapsulation: promise and progress. Nat. Med. 9 (2003) 104-107
30. Passerini N., and Craig D.Q.M. An investigation into the effects of residual water on the glass transition temperature of polylactide microspheres using modulated temperature DSC. J. Control. Rel. 73 (2001) 111-115
31. Ricci M., Blasi P., Giovagnoli S., Rossi C., Macchiarulo G., Luca G., Basta G., and Calafiore R. Ketoprofen controlled release from composite microcapsules for cell encapsulation: effect on post-transplant acute inflammation. J. Control. Rel. 107 (2005) 395-407
32. Robertson R.P. Dominance of cyclooxygenase-2 in the regulation of pancreatic islet prostaglandin synthesis. Diabetes 47 (1998) 1379-1383
33. Schade A., Niwa T., Takeuchi H., Hino T., and Kawashima Y. Aqueous colloidal polymer dispersion of biodegradable d,l-lactide/glicolide copolymer as basis for latex films: a new approach for the development of biodegradable depot system. Int. J. Pharm. 117 (1995) 209-217
34. Sorli C.H., Zhang H.-J., Armstrong M.B., Rajotte R.V., Maclouf J., and Robertson R.P. Basal expression of cyclooxygenase-2 and nuclear factor-interleukin 6 are dominant and coordinately regulated by interleukin 1 in the pancreatic islet. Proc. Natl. Acad. Sci. USA 95 (1998) 1788-1793
35. Soon-Shiong P., Heintz R., Merideth N., Yao Q.X., Yao Z., Zheng T., Murphy M., Moloney M.K., Schmehl M., Harris M., Mendez R., Mendez R., and Sanford P. Insulin-independence in a type I diabetic patient after encapsulated islet transplantation. Lancet 343 (1994) 950-951
36. Sung H., Meredith C., Johnson C., and Galis Z.S. The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. Biomaterials 25 (2004) 5735-5742
37. Vargas F., Vives-Pi M., Somoza N., Armengol P., Alcalde L., Martí M., Costa M., Serradell L., Dominguez O., Fernández-Llamazares J., Julian J., Sanmartí A., and Pujol-Borrell R. Endotoxin contamination may be responsible for the unexplained failure of human pancreatic islet transplantation. Transplantation 65 (1998) 722-727
38. Wajngot A., Giacca A., Grill V., Vranic M., and Efendic S. The diabetogenic effects of glucocorticoids are more pronounced in low- than in high-insulin responders. Proc. Natl. Acad. Sci. USA 89 (1992) 6035-6039